Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Biol Psychiatry. 2024 Apr 1;95(7):676-686. doi: 10.1016/j.biopsych.2023.07.022. Epub 2023 Aug 11.
The CYFIP1 gene, located in the neurodevelopmental risk locus 15q11.2, is highly expressed in microglia, but its role in human microglial function as it relates to neurodevelopment is not well understood.
We generated multiple CRISPR (clustered regularly interspaced short palindromic repeat) knockouts of CYFIP1 in patient-derived models of microglia to characterize function and phenotype. Using microglia-like cells reprogrammed from peripheral blood mononuclear cells, we quantified phagocytosis of synaptosomes (isolated and purified synaptic vesicles) from human induced pluripotent stem cell (iPSC)-derived neuronal cultures as an in vitro model of synaptic pruning. We repeated these analyses in human iPSC-derived microglia-like cells derived from 3 isogenic wild-type/knockout line pairs derived from 2 donors and further characterized microglial development and function through morphology and motility.
CYFIP1 knockout using orthogonal CRISPR constructs in multiple patient-derived cell lines was associated with a statistically significant decrease in synaptic vesicle phagocytosis in microglia-like cell models derived from both peripheral blood mononuclear cells and iPSCs. Morphology was also shifted toward a more ramified profile, and motility was significantly reduced. However, iPSC-CYFIP1 knockout lines retained the ability to differentiate to functional microglia.
The changes in microglial phenotype and function due to the loss of function of CYFIP1 observed in this study implicate a potential impact on processes such as synaptic pruning that may contribute to CYFIP1-related neurodevelopmental disorders. Investigating risk genes in a range of central nervous system cell types, not solely neurons, may be required to fully understand the way in which common and rare variants intersect to yield neuropsychiatric disorders.
位于神经发育风险位点 15q11.2 的 CYFIP1 基因在小胶质细胞中高度表达,但它在人类小胶质细胞功能中的作用与神经发育的关系尚不清楚。
我们在源自患者的小胶质细胞模型中生成了多个 CYFIP1 的 CRISPR(成簇的规则间隔的短回文重复序列)敲除,以表征功能和表型。我们使用外周血单核细胞重编程的类小胶质细胞样细胞,定量分析了源自人诱导多能干细胞 (iPSC) 衍生神经元培养物的突触小体 (分离和纯化的突触小泡) 的吞噬作用,作为突触修剪的体外模型。我们在源自 2 个供体的 3 对同源野生型/敲除系衍生的人类 iPSC 衍生的类小胶质细胞样细胞中重复了这些分析,并通过形态和运动进一步表征了小胶质细胞的发育和功能。
在源自外周血单核细胞和 iPSC 的类小胶质细胞样细胞模型中,使用正交 CRISPR 构建体对多个患者衍生细胞系中的 CYFIP1 进行敲除与突触小泡吞噬作用的统计学显著降低相关。形态也向更分支的形态转变,运动显著减少。然而,iPSC-CYFIP1 敲除系保留了分化为功能性小胶质细胞的能力。
本研究中观察到的由于 CYFIP1 功能丧失导致的小胶质细胞表型和功能的变化表明,它可能对突触修剪等过程产生潜在影响,这些过程可能导致与 CYFIP1 相关的神经发育障碍。在一系列中枢神经系统细胞类型中而不仅仅是神经元中研究风险基因,可能需要全面了解常见和罕见变异如何相互作用产生神经精神障碍。